In-hospital Cardiac Arrest - Dynamics and State Transitions
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to analyse transitions in cardiac rhythm and hemodynamic variables during resuscitation of patients with in-hospital cardiac arrest.
| Condition | Intervention |
|---|---|
|
Heart Arrest Death, Sudden, Cardiac |
Procedure: Cardiopulmonary resuscitation (CPR) Drug: Epinephrine Drug: Atropine Drug: Amiodarone Device: External defibrillator |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Dynamics and State Transitions During Resuscitation in In-hospital Cardiac Arrest |
- Survival to discharge [ Time Frame: 1 year ] [ Designated as safety issue: No ]
- Short-term survival [ Time Frame: minutes-days ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 300 |
| Study Start Date: | August 2009 |
| Estimated Study Completion Date: | June 2014 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |
-
Procedure: Cardiopulmonary resuscitation (CPR)
In-hospital cardiac arrest carries a grave prognosis, with survival to discharge in the range of 15-20%. Key factors determining outcome include the presenting cardiac rhythm, aetiology, and early initiation of resuscitation. Some cardiac rhythms benefit from defibrillation (shockable rhythms). During resuscitation patients may switch between shockable and non-shockable rhythms, and may show signs of spontaneous circulation temporarily. Depending on rhythm and according to guidelines, patients receive DC shocks (defibrillator) and/or i.v. adrenaline, atropine and amiodarone, which may affect state-transitions. We wish to make statistical analysis (time-series analysis, Markov modelling) of these state-transitions and variations in hemodynamic variables during resuscitation, related to CPR interventions and the cause of arrest. The cause of arrest will be determined based on chart records, interview with staff and autopsy if appropriate. One hypothesis is that differences in the patterns of state-transitions may reflect underlying aetiology, which may guide in future decision-making during resuscitation.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients with in-hospital cardiac arrest at St.Olavs Hospital (Trondheim, Norway) during the study period.
Inclusion Criteria:
- Patients with in-hospital cardiac arrest who are resuscitated
Exclusion Criteria:
- Younger than 18 years old
Contacts and Locations| Contact: Eirik Skogvoll, MD, PhD | +4772574549 | eirik.skogvoll@ntnu.no |
| Contact: Trond Nordseth, MD | +4797066399 | trond.nordseth@ntnu.no |
| Norway | |
| St.Olavs Hospital, Department of Anesthesia | Recruiting |
| Trondheim, Norway, 7014 | |
| Principal Investigator: Trond Nordseth, MD | |
| Sub-Investigator: Daniel Bergum, MD | |
| Study Chair: | Eirik Skogvoll, MD, PhD | St. Olavs Hospital |
| Principal Investigator: | Trond Nordseth, MD | St. Olavs Hospital |
More Information
Publications:
| Responsible Party: | St. Olavs Hospital |
| ClinicalTrials.gov Identifier: | NCT00920244 History of Changes |
| Other Study ID Numbers: | 4.2008.2402 (REK), 08/11457, 20708/2/IB |
| Study First Received: | June 12, 2009 |
| Last Updated: | November 3, 2011 |
| Health Authority: | Norway:National Committee for Medical and Health Research Ethics Norway: Norwegian Social Science Data Services Norway: Directorate of Health |
Keywords provided by St. Olavs Hospital:
|
Resuscitation Cardiac arrest State-transitions Markov |
Additional relevant MeSH terms:
|
Death, Sudden Heart Arrest Death, Sudden, Cardiac Death Pathologic Processes Heart Diseases Cardiovascular Diseases Epinephrine Atropine Epinephryl borate Amiodarone Adrenergic beta-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents |
Molecular Mechanisms of Pharmacological Action Pharmacologic Actions Physiological Effects of Drugs Bronchodilator Agents Autonomic Agents Peripheral Nervous System Agents Anti-Asthmatic Agents Respiratory System Agents Therapeutic Uses Mydriatics Adrenergic alpha-Agonists Sympathomimetics Vasoconstrictor Agents Cardiovascular Agents Anti-Arrhythmia Agents |
ClinicalTrials.gov processed this record on May 23, 2013